Earnings Outlook For Ultragenyx Pharmaceutical
Portfolio Pulse from Benzinga Insights
Ultragenyx Pharmaceutical (NASDAQ:RARE) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-2.06. The company's past performance shows a trend of share price changes following earnings reports. The stock was trading at $35.4 as of October 31, with a 52-week return of -6.18%.
November 01, 2023 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ultragenyx Pharmaceutical is expected to report an EPS of $-2.06. The company's stock price has historically been affected by its earnings reports. The stock is currently trading at $35.4, with a 52-week return of -6.18%.
The company's earnings report is a significant event that can impact its stock price. Given the company's history of share price changes following earnings reports and the current negative 52-week return, it is likely that the stock price may be negatively affected in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100